Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 3.61% is 67% below its 5-year average of 10.93%, around the middle of its 5-year range (-7.79%–21.05%).
22.97% above its 12-month average of 2.94%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -7.79%.
OPERATING MARGIN
3.61%
OPERATING MARGIN AVG TTM
2.94%
OPERATING MARGIN AVG 3Y
8.18%
OPERATING MARGIN AVG 5Y
10.93%
OPERATING MARGIN AVG 10Y
12.35%
OPERATING MARGIN AVG 15Y
10.92%
OPERATING MARGIN AVG 20Y
10.58%
CURRENT VS TTM AVG
+22.97%
CURRENT VS 3Y AVG
-55.87%
CURRENT VS 5Y AVG
-66.97%
CURRENT VS 10Y AVG
-70.77%
CURRENT VS 15Y AVG
-66.95%
CURRENT VS 20Y AVG
-65.88%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 505 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Bruker Corporation
Market Cap
$9.35B
Operating Margin
3.61%
TTM Avg
2.94%
3Y Avg
8.18%
5Y Avg
10.93%
Market Cap
$9.39B
Operating Margin
16.89%
TTM Avg
16.20%
3Y Avg
12.06%
5Y Avg
10.90%
Market Cap
$9.04B
Operating Margin
-24.28%
TTM Avg
-49.63%
3Y Avg
-136.06%
5Y Avg
-90.71%
Market Cap
$9.60B
Operating Margin
5.69%
TTM Avg
5.75%
3Y Avg
6.18%
5Y Avg
6.20%
Market Cap
$9.04B
Operating Margin
-891.33%
TTM Avg
-723.58%
3Y Avg
-500.53%
5Y Avg
-379.37%
Market Cap
$9.84B
Operating Margin
3.61%
TTM Avg
7.20%
3Y Avg
11.56%
5Y Avg
12.63%
Market Cap
$9.87B
Operating Margin
44.93%
TTM Avg
32.03%
3Y Avg
-38.09%
5Y Avg
-25.39%
Market Cap
$8.84B
Operating Margin
11.86%
TTM Avg
-8457.60%
3Y Avg
-4268.44%
5Y Avg
-2881.23%
Market Cap
$10.19B
Operating Margin
13.33%
TTM Avg
15.23%
3Y Avg
16.08%
5Y Avg
17.45%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bruker Corporation (BRKRP) | $9.35B | 3.61% | 2.94% | 8.18% | 10.93% |
| Insulet Corp. (PODD)vs › | $9.39B | 16.89% | 16.20% | 12.06% | 10.90% |
| Axsome Therapeutics, Inc. (AXSM)vs › | $9.04B | -24.28% | -49.63% | -136.06% | -90.71% |
| Henry Schein, Inc. (HSIC)vs › | $9.60B | 5.69% | 5.75% | 6.18% | 6.20% |
| Kymera Therapeutics, Inc. (KYMR)vs › | $9.04B | -891.33% | -723.58% | -500.53% | -379.37% |
| Bruker Corporation (BRKR)vs › | $9.84B | 3.61% | 7.20% | 11.56% | 12.63% |
| Krystal Biotech, Inc. (KRYS)vs › | $9.87B | 44.93% | 32.03% | -38.09% | -25.39% |
| Arrowhead Pharmaceuticals, Inc. (ARWR)vs › | $8.84B | 11.86% | -8457.60% | -4268.44% | -2881.23% |
| Align Technology, Inc. (ALGN)vs › | $10.19B | 13.33% | 15.23% | 16.08% | 17.45% |
| The Ensign Group, Inc. (ENSG)vs › | $10.08B | 8.52% | 8.41% | 8.37% | 8.78% |
Gross Margin
46.7%
Operating Margin
3.6%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -7.79% |
| 2026-03-31 | 5.47% |
| 2025-12-31 | 11.44% |
| 2025-09-30 | 4.07% |
| 2025-06-30 | 1.49% |
| 2025-03-31 | 3.97% |
| 2024-12-31 | 7.36% |
| 2024-09-30 | 7.88% |
| 2024-06-30 | 6.01% |
| 2024-03-31 | 8.98% |
| 2023-12-31 | 12.11% |
| 2023-09-30 | 16.76% |
| 2023-06-30 | 12.64% |
| 2023-03-31 | 17.90% |
| 2022-12-31 | 18.49% |
| 2022-09-30 | 21.05% |
| 2022-06-30 | 12.56% |
| 2022-03-31 | 16.22% |
| 2021-12-31 | 19.30% |
| 2021-09-30 | 18.59% |
| 2021-06-30 | 15.00% |
| 2021-03-31 | 16.06% |
| 2020-12-31 | 20.33% |
| 2020-09-30 | 15.88% |
| 2020-06-30 | 9.35% |
| 2020-03-31 | 3.87% |
| 2019-12-31 | 20.02% |
| 2019-09-30 | 16.85% |
| 2019-06-30 | 10.91% |
| 2019-03-31 | 9.08% |
| 2018-12-31 | 19.22% |
| 2018-09-30 | 14.81% |
| 2018-06-30 | 11.00% |
| 2018-03-31 | 8.83% |
| 2017-12-31 | 17.66% |
| 2017-09-30 | 11.46% |
| 2017-06-30 | 8.07% |
| 2017-03-31 | 9.77% |
| 2016-12-31 | 16.35% |
| 2016-09-30 | 11.65% |
| 2016-06-30 | 5.49% |
| 2016-03-31 | 9.06% |
| 2015-12-31 | 14.78% |
| 2015-09-30 | 7.12% |
| 2015-06-30 | 7.98% |
| 2015-03-31 | 4.30% |
| 2014-12-31 | 8.76% |
| 2014-09-30 | 1.17% |
| 2014-06-30 | 7.74% |
| 2014-03-31 | 4.86% |
| 2013-12-31 | 11.05% |
| 2013-09-30 | 7.18% |
| 2013-06-30 | 9.56% |
| 2013-03-31 | 3.10% |
| 2012-12-31 | 7.58% |
| 2012-09-30 | 13.47% |
| 2012-06-30 | 5.25% |
| 2012-03-31 | 8.48% |
| 2011-12-31 | 11.30% |
| 2011-09-30 | 8.96% |
| 2011-06-30 | 9.65% |
| 2011-03-31 | 7.20% |
| 2010-12-31 | 12.40% |
| 2010-09-30 | 12.67% |
| 2010-06-30 | 12.60% |
| 2010-03-31 | 9.69% |
| 2009-12-31 | 20.80% |
| 2009-09-30 | 9.81% |
| 2009-06-30 | 8.00% |
| 2009-03-31 | 6.20% |
| 2008-12-31 | 15.45% |
| 2008-09-30 | 6.25% |
| 2008-06-30 | 9.13% |
| 2008-03-31 | 6.68% |
| 2007-12-31 | 12.91% |
| 2007-09-30 | 8.70% |
| 2007-06-30 | 5.78% |
| 2007-03-31 | 7.02% |
| 2006-12-31 | 11.75% |
| 2006-09-30 | 6.66% |
| 2006-06-30 | 1.53% |
| 2006-03-31 | 2.43% |
| 2005-12-31 | 5.29% |
| 2005-09-30 | 4.14% |
| 2005-06-30 | 1.28% |
| 2005-03-31 | 3.39% |
| 2004-12-31 | 2.26% |
| 2004-09-30 | 0.38% |
| 2004-06-30 | -8.23% |
| 2004-03-31 | 2.88% |
| 2003-12-31 | -0.08% |
| 2003-09-30 | -8.80% |
| 2003-06-30 | 0.99% |
| 2003-03-31 | -1.44% |
| 2002-12-31 | 3.95% |
| 2002-09-30 | 8.95% |
